NEW YORK (GenomeWeb) – CareDx today announced that its European distributor of AlloMap tests, Diaxonhit, has signed a service sub-licensing agreement with the Strasbourg University Hospitals to perform all AlloMap testing at a dedicated facility in Strasbourg, France.

Diaxonhit is the exclusive distributor of AlloMap in Europe. The blood-based molecular diagnostic test allows clinicians to monitor heart transplant recipients for acute cellular rejection.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The ancestors of the Arizona bark scorpion and other scorpions and spiders underwent whole-genome duplication, KJZZ reports.

A cryptographic approach could help researchers keep genomic data private while researchers analyze it, Scientific American reports.

Andy Page, the former president of 23andMe, has joined a diabetes-management startup, according to CNBC.

In Cell this week: regulatory changes in pancreatic cancer, metabolic shifts in Alzheimer's disease, and more.